Journal for ImmunoTherapy of Cancer (Apr 2022)
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion
- Carl G Figdor,
- I Jolanda M de Vries,
- Camille Le Gall,
- Anna Cammarata,
- Lukas de Haas,
- Iván Ramos-Tomillero,
- Jorge Cuenca-Escalona,
- Kayleigh Schouren,
- Zacharias Wijfjes,
- Anouk M D Becker,
- Johanna Bödder,
- Yusuf Dölen,
- Georgina Flórez-Grau,
- Martijn Verdoes
Affiliations
- Carl G Figdor
- 1 Department of Tumor Immunology, Radboudumc, Nijmegen, The Netherlands
- I Jolanda M de Vries
- 1 Department of Tumor Immunology, Radboudumc, Nijmegen, The Netherlands
- Camille Le Gall
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- Anna Cammarata
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- Lukas de Haas
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- Iván Ramos-Tomillero
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- Jorge Cuenca-Escalona
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- Kayleigh Schouren
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- Zacharias Wijfjes
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- Anouk M D Becker
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- Johanna Bödder
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- Yusuf Dölen
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- Georgina Flórez-Grau
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- Martijn Verdoes
- Department of Tumor Immunology, Radboudumc Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
- DOI
- https://doi.org/10.1136/jitc-2021-004309
- Journal volume & issue
-
Vol. 10,
no. 4
Abstract
No abstracts available.
